XALIX

XALIX is an FDA drug label for the active ingredient SALICYLIC ACID manufactured by KMM Pharmaceuticals, LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20171025.

Generic: SALICYLIC ACID

Manufacturer: KMM Pharmaceuticals, LLC

Product Type: HUMAN PRESCRIPTION DRUG

Route: TOPICAL

Dosage Form:

NDC: 52187-525

Application:

Effective: 20171025

Indications & Usage

INDICATIONS AND USAGE: This product is indicated for the topical treatment and removal of common warts and plantar warts.

Dosage & Administration

DOSAGE AND ADMINISTRATION: Prior to applying this product, soak wart in warm water for five minutes. Remove any loose tissue by gently rubbing with a washcloth, emery board, or pumice stone. Dry the wart site thoroughly. Using the brush applicator supplied, apply this product twice to the entire wart surface, allowing the first application to dry before applying the second. Continue treatment once or twice a day or as directed by a physician. Be careful not to apply to surrounding skin. Clinically visible improvement normally occurs during the first or second week of therapy. Resolution may be expected after four to six weeks of this product’s use, though some warts may take longer to remove.

Contraindications

CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. Patients with diabetes or impaired blood circulation should not use this product. This product also should not be used on moles, birthmarks, and unusual warts with hair growing from them, or warts on the face.

Warnings

WARNINGS: KEEP OUT OF REACH OF CHILDREN. This product is flammable. Keep away from fire or flame. Keep bottle tightly closed when not in use.

Adverse Reactions

ADVERSE REACTIONS: Localized irritation may occur if this product is applied to normal skin surrounding the wart; however irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed. To report a serious adverse event, call 1-855-899-4237.

More from same ingredient

ACNE AND LINE CORRECTING SERUM

CLINIQUE LABORATORIES LLC

ACNE CLEANSING

CLINIQUE LABORATORIES LLC

Acne Advanced Clarifying Hydrator

Eminence Organic Skin Care Ltd.

Acne Advanced Clarifying Masque

Eminence Organic Skin Care Ltd.

Acne Advanced Cleansing

Eminence Organic Skin Care Ltd.